Successful treatment of enterovirus-induced myocarditis with interferon-α

Journal of Heart and Lung Transplantation

Volumn 22, Issue 2, 2003, Pages 214-217

  Daliento, Luciano ^a,b   Calabrese, Fiorella ^a   Tona, Francesco ^a   Caforio, Alida L P ^a   Tarsia, Giandomenico ^a   Angelini, Annalisa ^a   Thiene, Gaetano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; ENTEROVIRUS INFECTION; HEART FAILURE; HEMODYNAMICS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NAUSEA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VIRUS MYOCARDITIS;

EID: 0037314349     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00565-X     Document Type: Article

References (19)

1. Richardson P, Mckenna WJ, Bristow M, et al. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation 1996;1995:93:841-2.
2. Aretz H.T. Myocarditis The Dallas criteria. Hum Pathol. 18:1987;619-624.
3. Caforio A.L.P., Goldman J.H., Haven A.J. Circulating cardiac autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. Eur Heart J. 18:1997;270-275.
4. Caforio A.L.P., Bonifacio E., Stewart J., et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol. 15:1990;1527-1534.
5. Caforio A.L.P., Stewart J.T., Bonifacio E., Davies M.J., McKenna W.J., Bottazzo G.F. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy Relevance for autoimmunity? J Autoimmunity. 3:1990;187-200.
6. Noutsias M., Seeberg B., Schultheiss H.P., Kuhl U. Expression of cell adhesion molecules in dilated cardiomyopathy evidence for endothelial activation in inflammatory cardiomyopathy. Circulation. 99:1999;2124-2131.
7. Kuhl U., Noutsias M., Seeberg B., Schultheiss H.P. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart. 75:1996;295-300.
8. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy two-year follow-up results. Circulation. 104:2001;39-45.
9. Martino T.A., Liu P., Sole M.J. Enterovirus myocarditis and dilated cardiomyopathy a review of clinical and experimental studies. Rotbart H.A. Human Enterovirus Infections. 1995;291-350 American Society for Microbiology, Washington, DC.
10. Angelini A., Calzolari V., Calabrese F., et al. Myocarditis mimicking acute myocardial infarction role of endomyocardial biopsy in the differential diagnosis. Heart. 84:2000;245-250.
11. Kanda T., Nagaoka H., Kaneko K., et al. Synergistic effects of tacrolimus and human interferon-α A/D in murine viral myocarditis. J Pharmacol Exp Ther. 274:1995;487-493.
12. Wech P.K., Rinderknecht E., Estell D.A., Stebbing N. Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice. Infect Immun. 35:1982;660-665.
13. Matsumori A., Crumpacker C.S., Abelmann W.H. Prevention of viral myocarditis with recombinant human leukocyte interferon α A/D in murine model. J Am Coll Cardiol. 9:1987;1320-1325.
14. Siegener M.S., Heim A., Figulla H.R. Subclassification of dilated cardiomyopathy and interferon treatment. Eur Heart J. 16:(supplO):1995;147-149.
15. Miric M., Vasiljevic J., Bojic M., Popovic Z., Keserovic N., Pesic M. Long-term follow-up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones Initial results. Heart. 75:1996;596-601.
16. Terasaky F. Evolution to cardiomyopathy from acute eosinophilic pancarditis in Churge-Strauss syndrome. Heart Vessels. 12:(suppl1):1997;43.
17. Heim A., Stille-Siegener M., Kandolf R., Kreuzer H., Figulla H.R. Enterovirus-induced myocarditis hemodynamic deterioration with immunosuppressive therapy and successful application of interferon α Clin Cardiol. 17:1994;563-565.
18. Butterfield JH. Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Inter Med 1994;12:0648-53.
19. Tastis E. Treatment of Churge-Strauss syndrome with interferon alpha. (abstract) Arthritis Rheum. 39:(suppl):1996;S64.